Siglec Receptors Modulate Dendritic Cell Activation and Antigen Presentation to T Cells in Cancer

Interactions between sialylated glycans and sialic acid-binding immunoglobulin-like lectin (Siglec) receptors have been recently described as potential new immune checkpoint that can be targeted to improve anticancer immunity. Myeloid cells have been reported to express a wide range of different Sig...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Jinyu, Manni, Michela, Bärenwaldt, Anne, Wieboldt, Ronja, Kirchhammer, Nicole, Ivanek, Robert, Stanczak, Michal, Zippelius, Alfred, König, David, Rodrigues Manutano, Natalia, Läubli, Heinz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cell and Developmental Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8927547/
https://www.ncbi.nlm.nih.gov/pubmed/35309936
http://dx.doi.org/10.3389/fcell.2022.828916

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8927547/
https://www.ncbi.nlm.nih.gov/pubmed/35309936
http://dx.doi.org/10.3389/fcell.2022.828916

Ejemplares similares